Synthesis and evaluation of hetero- and homodimers of ribosome-targeting antibiotics: antimicrobial activity, in vitro inhibition of translation, and drug resistance.

In this study, we describe the synthesis of a full set of homo- and heterodimers of three intact structures of different ribosome-targeting antibiotics: tobramycin, clindamycin, and chloramphenicol. Several aspects of the biological activity of the dimeric structures were evaluated including antimicrobial activity, inhibition of in vitro bacterial protein translation, and the effect of dimerization on the action of several bacterial resistance mechanisms that deactivate tobramycin and chloramphenicol. This study demonstrates that covalently linking two identical or different ribosome-targeting antibiotics may lead to (i) a broader spectrum of antimicrobial activity, (ii) improved inhibition of bacterial translation properties compared to that of the parent antibiotics, and (iii) reduction in the efficacy of some drug-modifying enzymes that confer high levels of resistance to the parent antibiotics from which the dimers were derived.

[1]  A. Delcour,et al.  Outer membrane permeability and antibiotic resistance. , 2009, Biochimica et biophysica acta.

[2]  D. Arya,et al.  Click dimers to target HIV TAR RNA conformation. , 2012, Biochemistry.

[3]  Y. Tor,et al.  Enhanced RNA binding of dimerized aminoglycosides. , 1999, Bioorganic & medicinal chemistry.

[4]  S. Schroeder,et al.  Structure-activity relationship in the oxazolidinone-quinolone hybrid series: influence of the central spacer on the antibacterial activity and the mode of action. , 2003, Bioorganic & medicinal chemistry letters.

[5]  S. Garneau‐Tsodikova,et al.  Exploring the Substrate Promiscuity of Drug‐Modifying Enzymes for the Chemoenzymatic Generation of N‐Acylated Aminoglycosides , 2009, Chembiochem : a European journal of chemical biology.

[6]  S. K. Mahto,et al.  Expanding the nucleotide repertoire of the ribosome with post-transcriptional modifications. , 2007, ACS chemical biology.

[7]  Hiroshi Nikaido,et al.  Efflux-Mediated Drug Resistance in Bacteria , 2012, Drugs.

[8]  K. Farley,et al.  A New Resistance Gene, linB, Conferring Resistance to Lincosamides by Nucleotidylation in Enterococcus faecium HM1025 , 1999, Antimicrobial Agents and Chemotherapy.

[9]  T. Baasov,et al.  Dual-acting hybrid antibiotics: a promising strategy to combat bacterial resistance , 2010, Expert opinion on drug discovery.

[10]  J. Cate,et al.  Structures of the Escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action , 2010, Proceedings of the National Academy of Sciences.

[11]  D. Arya,et al.  Recognition of HIV TAR RNA by triazole linked neomycin dimers. , 2011, Bioorganic & medicinal chemistry letters.

[12]  Gerard D. Wright,et al.  Bacterial resistance to antibiotics: enzymatic degradation and modification. , 2005, Advanced drug delivery reviews.

[13]  Soonsil Hyun,et al.  An approach to enhance specificity against RNA targets using heteroconjugates of aminoglycosides and chloramphenicol (or linezolid). , 2004, Journal of the American Chemical Society.

[14]  S. Garneau‐Tsodikova,et al.  Unusual regioversatility of acetyltransferase Eis, a cause of drug resistance in XDR-TB , 2011, Proceedings of the National Academy of Sciences.

[15]  E. Westhof,et al.  Crystal structure of a complex between the aminoglycoside tobramycin and an oligonucleotide containing the ribosomal decoding a site. , 2002, Chemistry & biology.

[16]  Jessica L. Childs-Disney,et al.  Controlling the specificity of modularly assembled small molecules for RNA via ligand module spacing: targeting the RNAs that cause myotonic muscular dystrophy. , 2009, Journal of the American Chemical Society.

[17]  S. Garneau‐Tsodikova,et al.  Effects of Altering Aminoglycoside Structures on Bacterial Resistance Enzyme Activities , 2011, Antimicrobial Agents and Chemotherapy.

[18]  A Yonath,et al.  Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3 , 2001, The EMBO journal.

[19]  T. Izard,et al.  Cubic crystals of chloramphenicol phosphotransferase from Streptomyces venezuelae in complex with chloramphenicol. , 1999, Acta crystallographica. Section D, Biological crystallography.

[20]  S. Schwarz,et al.  Molecular basis of bacterial resistance to chloramphenicol and florfenicol. , 2004, FEMS microbiology reviews.

[21]  K. Ganesh,et al.  Oligonucleotides with (N-thymin-1-ylacetyl)-1-arylserinol backbone: chiral acyclic analogs with restricted conformational flexibility , 2001 .

[22]  F. Schluenzen,et al.  Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria , 2001, Nature.

[23]  S. Garneau‐Tsodikova,et al.  The Future of Aminoglycosides: The End or Renaissance? , 2010, Chembiochem : a European journal of chemical biology.

[24]  J. Poehlsgaard,et al.  The Cfr rRNA Methyltransferase Confers Resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A Antibiotics , 2006, Antimicrobial Agents and Chemotherapy.

[25]  Chi-Huey Wong,et al.  Design of Bifunctional Antibiotics that Target Bacterial rRNA and Inhibit Resistance-Causing Enzymes , 2000 .

[26]  A. Bashan,et al.  Ribosomal antibiotics: structural basis for resistance, synergism and selectivity. , 2004, Trends in biotechnology.

[27]  S. Garneau‐Tsodikova,et al.  Dissecting the cosubstrate structure requirements of the Staphylococcus aureus aminoglycoside resistance enzyme ANT(4'). , 2010, Biochemical and biophysical research communications.

[28]  L. Piddock,et al.  The importance of efflux pumps in bacterial antibiotic resistance. , 2003, The Journal of antimicrobial chemotherapy.

[29]  Gerard D. Wright.  Q&A: Antibiotic resistance: where does it come from and what can we do about it? , 2010, BMC Biology.

[30]  S. Garneau‐Tsodikova,et al.  Assessment of 6'- and 6'''-N-acylation of aminoglycosides as a strategy to overcome bacterial resistance. , 2011, Organic & biomolecular chemistry.

[31]  H. Neu,et al.  In vitro activity of chloramphenicol and thiamphenicol analogs , 1980, Antimicrobial Agents and Chemotherapy.

[32]  A. Eldar,et al.  6''-Thioether tobramycin analogues: towards selective targeting of bacterial membranes. , 2012, Angewandte Chemie.

[33]  Thomas A Steitz,et al.  Structures of five antibiotics bound at the peptidyl transferase center of the large ribosomal subunit. , 2003, Journal of molecular biology.

[34]  S. Garneau‐Tsodikova,et al.  The structural basis for substrate versatility of chloramphenicol acetyltransferase CATI , 2012, Protein science : a publication of the Protein Society.

[35]  L S Gonzalez,et al.  Aminoglycosides: a practical review. , 1998, American family physician.

[36]  A. Mankin,et al.  Antibiotics and the ribosome , 2006, Molecular microbiology.

[37]  J. Sutcliffe.  Antibiotics in development targeting protein synthesis , 2011, Annals of the New York Academy of Sciences.

[38]  A. Yonath,et al.  Antibiotics targeting ribosomes: resistance, selectivity, synergism and cellular regulation. , 2005, Annual review of biochemistry.

[39]  V. Ramakrishnan,et al.  Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics , 2000, Nature.

[40]  V. Ramakrishnan,et al.  The Structural Basis for the Action of the Antibiotics Tetracycline, Pactamycin, and Hygromycin B on the 30S Ribosomal Subunit , 2000, Cell.

[41]  R. E. Pachorek,et al.  Clindamycin in the Treatment of Streptococcal and Staphylococcal Toxic Shock Syndromes , 2000, The Annals of pharmacotherapy.